🔎 Trials Near Me

Akèy › Dematit atopik (Ekzema) › Kalifòni › San Diego

Etid klinik pou Dematit atopik (Ekzema) nan San Diego, CA

10 etid pou Dematit atopik (Ekzema) ap chèche patisipan nan sit nan ak bò kote San Diego (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment

Ap rekriteEtid obsèvasyon
  • University Clinical Trials- Site Number : 8400019, San Diego
Laj 12 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT07290803

A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema

Ap rekriteFaz 3
  • Investigational Drug Service - Rady Childrens Hospital-San Diego, San Diego
  • University of California, San Diego/ Rady Children's Hospital - San Diego, San Diego
Laj 2 a 11 · Tout sèks · Mizajou Sep 25, 2026 · NCT06807281

Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis

Ap rekriteFaz 2
  • Enveda Investigative Site, San Diego
  • Enveda Investigative Site, San Diego
Laj 18 a 75 · Tout sèks · Mizajou Sep 25, 2026 · NCT07298395

Real World Efficiency of Abrocitinib Treatment at Patients With Moderate to Severe Atopic Dermatitis Who Had Inadequate Response to Previous Biologic Therapies.

Ap rekriteEtid obsèvasyon
  • Allergy and Asthma Medical Group and Research Center, San Diego
Laj 12 ak plis · Tout sèks · Mizajou Aug 17, 2026 · NCT06899204

FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients

Ap rekriteFaz 1Volontè an sante akeyi
  • TCR Medical Corporation, San Diego
Laj 18 a 70 · Tout sèks · Mizajou Jul 22, 2026 · NCT06564389

A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis

Ap rekriteFaz 3
  • Leo Pharma Investigational site, San Diego
6 Months – 11 Years · Tout sèks · Mizajou Jul 7, 2026 · NCT06311682

A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab

Ap rekriteFaz 3
  • West Dermatology La Jolla /ID# 265014, San Diego
Laj 18 a 63 · Tout sèks · Mizajou Jul 6, 2026 · NCT06389136

Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2)

Ap rekriteFaz 1
  • University of California, San Diego: Dermatology Clinical Trials Unit, San Diego
Laj 6 ak plis · Tout sèks · Mizajou Jul 2, 2026 · NCT06504160

A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis

Ap rekriteFaz 2
  • Dermatology Cosmetic Laser Medical Associates of La Jolla, Inc., San Diego
  • West Dermatology La Jolla, San Diego
Laj 18 ak plis · Tout sèks · Mizajou May 4, 2026 · NCT05995964

Monitoring Pregnancy and Infant Outcomes Following Tralokinumab Exposure During Pregnancy in the US and Canada - PROTECT

Ap rekriteEtid obsèvasyon
  • University of California San Diego (UCSD), La Jolla · 11 mi lwen
Tout laj · Fanm · Mizajou Jan 28, 2025 · NCT05938478

Etid Dematit atopik (Ekzema) nan lòt vil

Lòt etid nan San Diego

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.